Innoviva, Inc. (INVA)
20.94
0.00 (0.00%)
USD |
NASDAQ |
Oct 28, 10:02
Innoviva Price : 20.94 for Oct. 28, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 27, 2026 | 20.97 | 21.06 | 20.75 | 20.94 | 584440.0 |
| Oct 26, 2026 | 20.77 | 21.22 | 20.77 | 21.05 | 569096.0 |
| Oct 23, 2026 | 20.88 | 20.94 | 20.51 | 20.66 | 978553.0 |
| Oct 22, 2026 | 21.05 | 21.27 | 20.92 | 21.06 | 452078.0 |
| Oct 21, 2026 | 21.20 | 21.36 | 20.89 | 20.91 | 442222.0 |
| Oct 20, 2026 | 21.31 | 21.49 | 21.12 | 21.28 | 507564.0 |
| Oct 19, 2026 | 20.68 | 21.15 | 20.68 | 21.08 | 590514.0 |
| Oct 16, 2026 | 20.97 | 20.97 | 20.56 | 20.78 | 550486.0 |
| Oct 15, 2026 | 21.33 | 21.76 | 20.83 | 20.86 | 672982.0 |
| Oct 14, 2026 | 20.79 | 21.18 | 20.73 | 20.97 | 673510.0 |
| Oct 13, 2026 | 21.55 | 21.55 | 20.70 | 20.74 | 811565.0 |
| Oct 12, 2026 | 21.27 | 21.48 | 21.12 | 21.45 | 521194.0 |
| Oct 09, 2026 | 20.80 | 21.28 | 20.78 | 21.21 | 507581.0 |
| Oct 08, 2026 | 21.05 | 21.05 | 20.73 | 20.87 | 612353.0 |
| Oct 07, 2026 | 20.78 | 21.10 | 20.78 | 21.06 | 636391.0 |
| Oct 06, 2026 | 20.78 | 20.97 | 20.62 | 20.83 | 679632.0 |
| Oct 05, 2026 | 20.53 | 20.74 | 20.45 | 20.64 | 993390.0 |
| Oct 02, 2026 | 20.60 | 20.76 | 20.50 | 20.50 | 774707.0 |
| Oct 01, 2026 | 21.28 | 21.28 | 20.53 | 20.55 | 927091.0 |
| Sep 30, 2026 | 21.11 | 21.45 | 21.06 | 21.21 | 1.100M |
| Sep 29, 2026 | 21.19 | 21.19 | 20.74 | 21.11 | 555808.0 |
| Sep 28, 2026 | 20.74 | 21.39 | 20.59 | 21.23 | 854634.0 |
| Sep 25, 2026 | 20.70 | 20.78 | 20.35 | 20.74 | 623374.0 |
| Sep 24, 2026 | 20.28 | 20.79 | 20.28 | 20.66 | 1.368M |
| Sep 23, 2026 | 21.11 | 21.36 | 20.23 | 20.24 | 4.031M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Merck & Co., Inc. | 141.56 |
| Zevra Therapeutics, Inc. | 10.18 |
| ANI Pharmaceuticals, Inc. | 71.02 |
| Corcept Therapeutics, Inc. | 87.08 |
| Veru, Inc. | 2.255 |
Price Related Metrics
| PE Ratio | 5.101 |
| PS Ratio | 3.790 |
| PEG Ratio | 0.0045 |
| Price to Book Value | 1.233 |
| Price to Free Cash Flow | 9.078 |
| Earnings Yield | 19.60% |
| Market Cap | 1.521B |
| PEGY Ratio | 0.0045 |
| Operating PE Ratio | 10.58 |
| Normalized PE Ratio | 9.158 |